Tragia L. Genus: History
View Latest Version
Please note this is an old version of this entry, which may differ significantly from the current revision.
Subjects: Chemistry, Medicinal
Contributor:
Juan Romero-Benavides

Tragia L. is a genus of plants belonging to the Euphorbiaceae family with worldwide intertropical distribution, composed of more than 150 species.

  • Tragia L.
  • Genus
  • Distribution
  • Biological Activity
  • Composition

1. Genus

The genus Tragia is one of the 317 genera in the Euphorbiaceae family. There are 161 accepted names belonging to 154 species in the Tragia genus, with “pantropical and warm temperate distribution” [1][2]. The etymology for the name of this genus comes from the Greek tragos, meaning goat. This name may stem either from the name of the German botanist Hieronymus Bock—Bock means “ram” or “he-goat” in German, or from the hairy appearance of the plant that would resemble a male goat [3].
Tragia species exhibit very ample morphological characters: they are perennial plants with herb, shrub, subshrub and twining vine growth habits, with lanceolate leaves presenting either entire or serrated margins. Plants belonging to this genus sting when touched due to the presence of leaf hairs with a needle-shaped crystal of calcium oxalate (raphide) in the terminal cells that is expelled on contact and punctures the skin, allowing irritants to enter and cause transient stinging [4][5], presumably a defense mechanism against herbivores [6]. Several common names for Tragias, such as noseburn (Tragia spp.), Indian stinging nettle (T. involucrata), fireman (T. volubilis) or stinging nettle creeper (T. durbanensis), are due to this stinging property.
Species belonging to Euphorbiaceae in general and to Tragia in particular are still not fully settled [7], as new species are being discovered [8] and species are being reassigned to other genera [1][9], so the number of species in the genus is still subject to change.

2. Distribution and Localization

Species belonging to the Tragia genus are present in subtropical America, Eastern and Southern Africa, the Indian subcontinent and Northeastern Australia. Of the 154 species listed in the genus [10], 94 are found in Africa, 48 in America, 10 in Asia and 3 in Oceania, with some species such as T. arabica and T. plukenetii present both in Africa and Asia.

3. Ethnopharmacological Usage

Of the more than 150 species of the genus, few appear in the scientific literature, and even fewer are mentioned from an ethnopharmacological perspective. Notwithstanding, Tragia species are a part of traditional medicinal systems of East Africa and the Indian subcontinent, such as Siddha and Ayurveda [11], with documented uses of T. involucrata appearing as early as the 1st century CE [12] and with only a handful of mentions of Tragia species in the New World pharmacopoeia, concerning mostly topical applications. There is concern over an excessive use of Tragia species, e.g., Tragia bicolor, which poses a conservation hazard [13][14].
Most of the interest in this genus has been focused on four species: Tragia involucrata, Tragia spathulata, Tragia plukenetii and Tragia benthamii [15], with the bulk of the research focused on T. involucrata. Nevertheless, several more species and their medicinal uses appear in literature.
According to the ATC classification, the most frequent ethnopharmacological uses of Tragia spp. in ethnopharmacology are: genitourinary system and sex hormones, with 19% of occurrences (15 of 77); nervous system, with 12%; and alimentary tract and metabolism, anti-infective for systemic use and antineoplastic and immunomodulating agents with 10% of occurrences each. The “various” classification presents 17% of occurrences, which include non-specified and vague uses, such as “toxic” or “medicinal”.
As for the morphological structures used per species, the most common are the leaves, 38%; followed by “not specified”, 33%; whole plant, 15%; roots, 13% and a single occurrence of endophytes (3%).

4. Biological Activity

Biological activity tests of Tragia, both in vitro and in vivo, are performed mostly with plant extracts and to a much lesser degree with essential oils: leaf, root or the whole plant, although ethnopharmacological uses mostly employ the plant via infusions, decoctions or ashes [15][16]. Different solvents and solvent mixtures have been used for the extracts, mainly methanol and ethanol. Due to the presence of Tragia in ethnomedical traditions in Africa and Asia, there is a team of research about the bioactivity of Old World Tragia extracts that have confirmed their activity and potency in some cases. Not all the health claims or traditional uses recorded have been validated through research. Again, the bulk of the research is centered on T. involucrata.

4.1. In Vitro Activity

Extracts of T. benthamii, T. brevipes, T. involucrata, T. pungens and T. spatulatha have been tested to ascertain their in vitro activity for a variety of uses.
In vitro biological activity tests devote the most attention to leaves (36%), with whole plant and root used to a lesser extent, with both 14%. Extraction solvents are methanol (47%), DCM (5%), Ethyl acetate (10%), water (6%), chloroform (5%), petroleum ether (5%), ethanol (5%) and acetone (5%). This solvent usage supports the assumption that most active compounds are moderately polar and are thus extracted with polar solvents.
Testing centers on antibacterial (41%) and antifungal (18%) activity of the extracts, with antiproliferative (12%) and antidiabetic, antiurolithiatic, radioprotective, immunomodulatory and cytotoxic effects (6% each) behind. This is a different profile than what was found in the ethnomedicinal claims, which centers on the genitourinary system and sex hormones. This is justified because aphrodisiacs do not have the expected properties [17].

4.2. In Vivo Activity

Besides in vitro activity testing, research has been done in animal models, mostly mice and also chicks, with at least one clinical trial performed in humans.
Most of the research (73%) centers on T. involucrata, with T. plukenetii (18%), T. benthamii (9%) and T. furialis (5%) behind. In vivo assay extracts were obtained from leaves (29%), whole plant (25%), root (21%) and aerial parts (8%). Solvents used are methanol (48%), ethanol (26%) and water (13%), which shows that most active compounds are polar and are thus extracted with polar solvents.
For both in vitro and in vivo testing, the most common effect is antibacterial and antimicrobial with 22% of the reviewed studies. This is higher than the 10% reported in the ethnopharmacological uses. Effects having to do with cancer prevention and treatment—antiproliferative, antitumor, cytotoxic immunomodulatory and radioprotective—add up to 17% of the reported effects, which makes it the second most frequent use. Analgesic and anti-inflammatory activity is equally reported in 10% of the tests.
The findings reported in literature validate several medicinal use cases for Tragia species and dismiss some claims, e.g., T. meyeriana as an antineoplastic [18].

5. Phytochemical Composition

Phytochemical studies allow for the identification, separation and isolation of compounds of interest [19]. Based on phytochemical screenings published in the literature, the main secondary metabolites found in Tragia species extracts are alkaloids, glycosides, flavonoids, and sterols [15][20].
Some compounds found in plants belonging to the Tragia genus, classified according to their chemical nature, are listed in Table 1. Where applicable, the biological activity of the identified compound has been mentioned.
Table 1. Compounds isolated/identified in Tragia extracts and oils and their biological effect.
No. Compound Identified Isolated Methodology Used Species Collection area Plant Organ Used Use Effect Reference
Acetal
1 1,1-diethoxy-2- methylpropane X   Ethanol extract
GC, MS		 T. plukenetii NS Whole plant NS NS [21]
        Aldehydes
2 16-heptadecenal X   Ethanol extract
GC, MS		 T. plukenetii NS Whole plant NS NS [21]
3 Hexanal X   Hydrodistillation
GC/GC-MS		 T. benthamii Ibadan, Nigeria Leaves NS NS [22]
        Alkaloid
4 (E)-4-(1-hydroxypropyl)-7,8-dimethyl-9-(prop-1-en-1-yl)-[1,3] dioxolo [4,5-g]quinolin-6(5H)-one X X Acidified ethanol extract
GC, MS, LC		 T. plukenetii NS Whole plant NS NS [21]
Esters
5 4-oxo-4H-pyran-2,6-dicarboxylic acid bis-[6-methyl-heptyl] ester X X Ethanol extract
IR
1H, 13C NMR, MS		 T. involucrata Salem, India Roots Antidiabetic Blood glucose reduction [23]
6 Ethyl linoleate X X Ethanol extract
GC, MS		 T. plukenetii NS Whole plant NS NS [21]
7 Ethyl palmitate X X Ethanol extract
GC, MS		 T. plukenetii NS Whole plant NS NS [21]
        Ether
8 Vinyl hexyl ether X X Aqueous extract
GC, MS		 T. involucrata Tamil Nadu, India Leaf Antibacterial
Escherichia coli
Proteus vulgaris
Staphylococcus aureus		 MBC 12.25 μg/mL [24][25]
Flavonoids
9 3-(2,4-dimethoxyphenyl)-6,7-dimethoxy-2,3-dihydrochromen-4-one X X Ethyl acetate extract
FTIR, MS, 1H NMR		 T. involucrata Odisha, India Root Antibacterial
Fungicidal		 MIC 1.25-12.5 μg/mL [26]
10 Iridin X X Ethyl acetate extract
FTIR, MS, 1H NMR		 T. involucrata Odisha, India Root Toxic   [26]
11 Quercetin X X Ethyl acetate extract
FTIR, MS, 1H NMR		 T. involucrata Odisha, India Root Antioxidant   [26]
12 Rutin X X Ethyl acetate extract
FTIR, MS, 1H NMR		 T. involucrata Odisha, India Root Antioxidant   [26]
Heterocycle
13 2,5-dithia-3,6-diazabicyclo[2.2.1]heptane X X 95% aqueous ethanol extraction
1H, 13C NMR		 T. benthamii Ibadan, Nigeria Whole plant NS   [27]
Hydrocarbons
14 2,6-dimethylheptane X X Aqueous extract
GC, MS		 T. involucrata Tamil Nadu, India Leaf Antibacterial
Proteus vulgaris		 MBC 10 μg/mL [24]
15 2,4-dimethylhexane X X Aqueous extract
GC, MS		 T. involucrata Tamil Nadu, India Leaf Antibacterial
Staphylococcus aureus		 MBC 12.25 μg/mL [24]
16 2-methylnonane X X Aqueous extract
GC, MS		 T. involucrata Tamil Nadu, India Leaf Antibacterial
Escherichia coli
Proteus vulgaris
Staphylococcus aureus		 MIC 5.0 μg/mL [24]
17 Shellsol
(2-methyldecane)		 X X Aqueous extract
GC, MS		 T. involucrata Tamil Nadu, India Leaf Antibacterial
Proteus vulgaris
Staphylococcus aureus		 MBC 25.0 μg/mL [24]
18 3,5-di-tert-butyl-4-hydroxyanisole X X 95% aqueous ethanol extraction
1H, 13C NMR		 T. benthamii Ibadan, Nigeria Whole plant Antioxidant   [27]
19 5-hydroxy-1-methylpiperdin-2-one X X Methanol extract
IR, 1H, 13C RMN, LC		 T. involucrata Kerala, India Leaf Antihistamine Muscle relaxant, bronchodilating and anti-allergic effects [28]
Polyols
20 Erythritol X X 95% aqueous ethanol extraction
1H, 13C NMR		 T. benthamii Ibadan, Nigeria Whole plant NS NS [27]
21 Glycerol X X 95% aqueous ethanol extraction
1H, 13C NMR		 T. benthamii Ibadan, Nigeria Whole plant NS NS [27]
Terpenoids
22 10,13-dimethoxy-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[α]phenanthrene. X X Ethyl acetate extract
FTIR, MS, 1H NMR		 T. involucrata Odisha, India Root NS NS [26]
23 Stigmasterol X   Aqueous extract
GC, MS		 T. involucrata   Leaf NS NS [24]
24 Caryophyllene X   Hydrodistillation
GC/GC-MS		 T. benthamii Ibadan, Nigeria Leaves Anti inflammatory   [22]
25 Citronellal X X Ethanol extract
IR, 1H RMN, LC		 T. ramosa Maharashtra, India Leaves Antibacterial   [29]
26 Clerodane X X Ethanol extract
IR, 1H RMN, LC		 T. ramosa Maharashtra, India Leaves NS NS [29]
27 Geranylacetone X   Hydrodistillation
GC/GC-MS		 T. benthamii Ibadan, Nigeria Leaves NS NS [22]
28 Neophytadiene (2-(4,8,12-Trimethyltridecyl) buta-1,3-diene) X X Ethanol extract
GC, MS		 T. plukenetii NS Whole plant NS NS [21]
29 Phytol X X 95% aqueous ethanol extraction
1H, 13C NMR		 T. benthamii Ibadan, Nigeria Whole plant NS NS [27]
30 Squalene (all trans) X X Ethanol extract
GC, MS		 T. plukenetii NS Whole plant NS NS [21]
31 α-terpinene X X Ethanol extract
IR, 1H RMN, LC		 T. ramosa Maharashtra, India Leaves Antiinflammatory,
Antimicrobial		 NS [29]
Identification of the compounds relies heavily on spectroscopic and spectrometric methods [19], and chromatography retention times and comparison with the literature are also used for tentative identification.
A strength of the genus is its diversity and its pantropical distribution, which makes it readily available in most tropical countries. A weakness would be that, despite the interest shown concerning T. involucrata and other traditionally medicinal species, there appear to be no drugs derived from plants of these species, remaining in the realm of herbal remedies and plant extracts, entailing less medicinal interest than other genera of the Euphorbiaceae family, notably Euphorbia [7]. This can be attributed to the stage of research, with most work performed in vitro or in vivo and with a single clinical trial [30]. Hopefully the current research will advance into new drugs.

This entry is adapted from the peer-reviewed paper 10.3390/plants10122717

References

  1. Gillespie, L.J.; Cardinal-McTeague, W.M.; Wurdack, K.J. Monadelpha (Euphorbiaceae, Plukenetieae), a New Genus of Tragiinae from the Amazon Rainforest of Venezuela and Brazil. PhytoKeys 2020, 169, 119–135.
  2. POWO Tragia Plum. Ex L. | Plants of the World Online | Kew Science. Available online: http://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:327688-2 (accessed on 25 October 2021).
  3. Urtecho, R. Tragia—FNA. Available online: http://dev.semanticfna.org/Tragia (accessed on 26 April 2021).
  4. Naudé, T.W.; Naidoo, V. Oxalates-containing plants. In Veterinary Toxicology; Elsevier: Amsterdam, The Netherlands, 2007; pp. 880–891. ISBN 978-0-12-370467-2.
  5. Prasad, R.; Shivay, Y.S. Oxalic Acid/Oxalates in Plants: From Self-Defence to Phytoremediation. Curr. Sci. 2017, 112, 1665–1667.
  6. Ensikat, H.-J.; Wessely, H.; Engeser, M.; Weigend, M. Distribution, Ecology, Chemistry and Toxicology of Plant Stinging Hairs. Toxins 2021, 13, 141.
  7. Mwine, J.T.; Damme, P.V. Why Do Euphorbiaceae Tick as Medicinal Plants? A Review of Euphorbiaceae Family and Its Medicinal Features. J. Med. Plants Res. 2011, 5, 652–662.
  8. Freire de Sá Cordeiro, W.P.; Athiê-Souza, S.M.; Laurênio de Melo, A.; Ferreira de Sales, M. A New Endangered Species of Tragia (Euphorbiaceae) from the Brazilian Atlantic Forest. Syst. Bot. 2020, 45, 839–844.
  9. Freire de Sá Cordeiro, W.P.; Athiê-Souza, S.M.; Buril, M.T.; de Melo, A.L.; de Sales, M.F. Chicomendes (Euphorbiaceae, Tragiinae): A New Amazonian Genus Segregated from Tragia. Plant Syst. Evol. 2021, 307, 46.
  10. Govaerts, R. World Checklist and Bibliography of Euphorbiaceae (and Pandaceae); Royal Botanic Gardens: Kew, UK, 2000; Volume 1, ISBN 978-1-900347-83-9.
  11. Kar, A.; Choudhary, B.K.; Bandyopadhyay, N.G. Comparative Evaluation of Hypoglycaemic Activity of Some Indian Medicinal Plants in Alloxan Diabetic Rats. J. Ethnopharmacol. 2003, 84, 105–108.
  12. Pallie, M.S.; Perera, P.K.; Kumarasinghe, N.; Arawwawala, M.; Goonasekara, C.L. Ethnopharmacological Use and Biological Activities of Tragia involucrata L. Evid. Based Complement. Altern. Med. 2020, 2020, 1–17.
  13. Abdulhameed, S.; Pradeep, N.S.; Sugathan, S. (Eds.) . Bioresources and Bioprocess in Biotechnology, 1st ed.; Springer: Singapore, 2017; ISBN 978-981-10-3571-5.
  14. Jose, P.A.; Hussain, K.H.; Sreekumar, V.B. Developing an Information System for the Rare Endangered and Threatened (RET) Plants of Southern Western Ghats; Kerala Forest Research Institute: Peechi, India, 2014; p. 42.
  15. Reddy, B.S.; Rao, N.R.; Vijeepallam, K.; Pandy, V. Phytochemical, Pharmacological and Biological Profiles of Tragia Species (Family: Euphorbiaceae). Afr. J. Tradit. Complement. Altern. Med. 2017, 14, 105–112.
  16. Pascaline, J.; Charles, M.; George, O.; Lukhoba, C. Ethnobotanical Survey and Propagation of Some Endangered Medicinal Plants from South Nandi District of Kenya. J. Anim. Plant Sci. 2012, 8, 28.
  17. Leonti, M.; Casu, L. Ethnopharmacology of Love. Front. Pharmacol. 2018, 9, 567.
  18. Charlson, A.J. Antineoplastic Constituents of Some Southern African Plants. J. Ethnopharmacol. 1980, 2, 323–335.
  19. Altemimi, A.; Lakhssassi, N.; Baharlouei, A.; Watson, D.; Lightfoot, D. Phytochemicals: Extraction, Isolation, and Identification of Bioactive Compounds from Plant Extracts. Plants 2017, 6, 42.
  20. Thangiah, A.S.; Mutuku, N.; Ngule, E.; Francis, R. Qualitative Analysis of Phytoconstituents in Tragia Brevipes Plant. Int. J. Pharm. Res. Anal. 2018, 3, 93–98.
  21. Antony, C. Phytochemical and Spectral Study of the Medicinal Plant: Tragia Plukenetii. J. Pharm. Res. 2012, 5, 1701–1703.
  22. Olaoye, S.B.; Ibrahim, A.O.; Zhiqiang, L. Chemical Compositions and Radical Scavenging Potentials of Essential Oils from Tragia benthamii (BAKER) and Cissus Aralioides (WELW). J. Biol. Act. Prod. Nat. 2016, 6, 59–64.
  23. Sivajothi, V.; Dakappa, S.S. In Vitro and in Silico Antidiabetic Activity of Pyran Ester Derivative Isolated from Tragia Cannabina. Asian Pac. J. Trop. Biomed. 2014, 4, S455–S459.
  24. Samy, R.P.; Gopalakrishnakone, P.; Houghton, P.; Ignacimuthu, S. Purification of Antibacterial Agents from Tragia involucrata—A Popular Tribal Medicine for Wound Healing. J. Ethnopharmacol. 2006, 107, 99–106.
  25. Gobalakrishnan, R.; Kulandaivelu, M.; Bhuvaneswari, R.; Kandavel, D.; Kannan, L. Screening of Wild Plant Species for Antibacterial Activity and Phytochemical Analysis of Tragia involucrata L. J. Pharm. Anal. 2013, 3, 460–465.
  26. Panda, D.; Dash, S.K. Phytochemical Examination and Antimicrobial Activity of Various Solvent Extracts and the Selected Isolated Compounds from Roots of Tragia involucrata Linn. Int. J. Pharm. Sci. Drug Res. 2012, 4, 44–48.
  27. Balogun, O.S.; Oladosu, I.A.; Liu, Z. Isolation of 2, 5-Dithia-3, 6-Diazabicyclo Heptane and GC-MS Analysis of Silylated Extract from Tragia benthamii. Ife J. Sci. 2020, 22, 75–80.
  28. Alagar Yadav, S.; Ramalingam, S.; Jabamalai Raj, A.; Subban, R. Antihistamine from Tragia involucrata L. Leaves. J. Complement. Integr. Med. 2015, 12, 217–226.
  29. Suryawanshi, V. Extraction and Isolation of Clerodane as a Bioactive Molecule from Tragia Ramosa. J. Pharmacogn. Phytochem. 2019, 8, 1135–1138.
  30. Pallie, M.; Perera, P.; Goonasekara, C.; Kumarasinghe, N.; Arawwawala, M. Efficacy and Safety of Freeze-Dried Form of Tragia involucrata L. Decoction in Treating Diabetes: A Randomized Controlled Clinical Trial. Clin. Trials Degener. Dis. 2020, 5, 31–36.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
This entry is offline, you can click here to edit this entry!
ScholarVision Creations
Feedback